title: Naproxen kinetics and disease activity in rheumatoid arthritis: a within-patient study.
abstract: The effects of rheumatoid arthritis disease activity on the pharmacokinetics of the highly albumin-bound nonsteroidal anti-inflammatory drug naproxen were studied in six patients during chronic therapy. In the same patients, kinetics during active disease were compared with those in improvement. Active disease is commonly associated with hypoalbuminemia: 30 +/- 4 gm/L vs. 41 +/- 2 gm/L (mean +/- SD) at the time of improvement. Total naproxen concentrations were significantly lower in active disease, together with a larger apparent volume of distribution (10.6 +/- 1.8 L vs. 8.4 +/- 1.3 L; P less than 0.05) and total body clearance (0.79 +/- 1.8 L/hr vs. 0.59 +/- 0.14 L/hr; P less than 0.001). Peak unbound naproxen concentrations were 29% +/- 19% (P less than 0.05) lower at the time of improvement. The unbound clearance was found diminished during active disease (390 +/- 277 L/hr) in comparison with improvement (488 +/- 343 L/hr; P less than 0.05). Clinical implications of the alterations in naproxen kinetics induced by polyarticular inflammation in patients with rheumatoid arthritis are discussed.
authors.affiliation: Department of Medicine, University Hospital St. Radbound, Nijmegen, The Netherlands.
authors.forename: F A
authors.initials: FA
authors.lastname: Van den Ouweland
authors.forename: F W
authors.initials: FW
authors.lastname: Gribnau
authors.forename: C A
authors.initials: CA
authors.lastname: Van Ginneken
authors.forename: Y
authors.initials: Y
authors.lastname: Tan
authors.forename: L B
authors.initials: LB
authors.lastname: Van de Putte
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D012709:Serum Albumin; D009288:Naproxen